SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BBII
BBII 0.0550+37.5%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pat w. who wrote (5)2/15/1998 1:08:00 PM
From: Bexar  Read Replies (1) of 28
 
Looks like all you need is more Volume!

Business Summary
Boston Biomedica, Inc. is a provider of proprietary quality control products for use with in vitro diagnostic test kits for the detection, analysis and monitoring of infectious diseases. For the 9 months ended 9/97, total revenues rose 37% to $15M. Net income rose from $246K to $570K.
Revenues reflect overall sales increase in Quality Control products. Earnings reflect an increase in gross profit due to improved margin in services.

Outstanding Shares = 4.47M
Float = 1.6

On Balanced Volume (OBV) going up while stock going down, (good sign!)
Watching BBII ;-)

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext